Raloxifene, a Mixed Estrogen Agonist/Antagonist, Induces Apoptosis through Cleavage of BAD in TSU-PR1 Human Cancer Cells

This publication has 35 references indexed in Scilit:

• Ligand-, Cell-, and Estrogen Receptor Subtype (α/β)-dependent Activation at GC-rich (Sp1) Promoter Elements
  Journal of Biological Chemistry, 2000
• Reduction of Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis Treated With RaloxifeneResults From a 3-Year Randomized Clinical Trial
  JAMA, 1999
• The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women
  JAMA, 1999
• An estrogen receptor basis for raloxifene action in boneProceedings of Xth International Congress on Hormonal Steroids, Quebec, Canada, 17–21 June 1998.
  The Journal of Steroid Biochemistry and Molecular Biology, 1999
• Interaction of Estrogenic Chemicals and Phytoestrogens with Estrogen Receptor β
  Endocrinology, 1998
• Tissue Distribution and Quantitative Analysis of Estrogen Receptor-α (ERα) and Estrogen Receptor-β (ERβ) Messenger Ribonucleic Acid in the Wild-Type and ERα-Knockout Mouse
  Endocrinology, 1997
• ERβ: Identification and characterization of a novel human estrogen receptor
  FEBS Letters, 1996
• Cloning of a novel receptor expressed in rat prostate and ovary.
  Proceedings of the National Academy of Sciences, 1996
• Selective estrogen receptor modulators: pharmacological profile in the rat uterus.
  Journal of the Society for Gynecologic Investigation, 1996
• Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A
  Nature, 1986